APA

Shankaran V., Mummy D., Koepl L., Bansal A., Mirick D. K., Yu E., Morlock R., Ogale S. & Ramsey S. D. (20150410). Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer. : The oncologist.

Chicago

Shankaran Veena, Mummy David, Koepl Lisel, Bansal Aasthaa, Mirick Dana K, Yu Elaine, Morlock Rob, Ogale Sarika and Ramsey Scott D. 20150410. Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer. : The oncologist.

Harvard

Shankaran V., Mummy D., Koepl L., Bansal A., Mirick D. K., Yu E., Morlock R., Ogale S. and Ramsey S. D. (20150410). Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer. : The oncologist.

MLA

Shankaran Veena, Mummy David, Koepl Lisel, Bansal Aasthaa, Mirick Dana K, Yu Elaine, Morlock Rob, Ogale Sarika and Ramsey Scott D. Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer. : The oncologist. 20150410.